Skip to content

Drug interactions

Larotrectinib + Midazolam

Severity: Moderate

Larotrectinib and Midazolam: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Larotrectinib is a CYP3A4 substrate and can moderately inhibit CYP3A4, which may raise midazolam concentrations. This could lead to deeper or longer sedation.

What this interaction means in plain words

Larotrectinib and Midazolam can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Larotrectinib belongs to Oncology; Midazolam belongs to Central Nervous System.

Evidence level: Moderate

Why it happens

Larotrectinib inhibits CYP3A4, reducing midazolam clearance.

What to do

Monitor sedation and respiratory function, and reduce the midazolam dose if needed. Use particular care with oral midazolam.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Larotrectinib and Midazolam, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Larotrectinib with Midazolam?

MediHelp rates the interaction as moderate. Larotrectinib and Midazolam can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Larotrectinib is a CYP3A4 substrate and can moderately inhibit CYP3A4, which may raise midazolam concentrations. This could lead to deeper or longer sedation.

How serious is the interaction between Larotrectinib and Midazolam?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor sedation and respiratory function, and reduce the midazolam dose if needed. Use particular care with oral midazolam.

What other medicines interact with Midazolam?

MediHelp also lists interactions of Midazolam with, for example, Atazanavir, Cobicistat, Darunavir. The full list is on the Midazolam page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in